Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra's Cannabinoid-based drug pipeline as opioid alternative.

Investor Presentation Deck

This content is available to members only.

If you are an existing member, please LOGIN

Not a member? Sign up for a FREE trial account now ($49 per month value), and get immediate access. Register New Account Free Membership Log in if you wish to renew an existing subscription. Username Email First Name Last Name Password Password Again .

Institutional / team access subscriptions, contact Melissa Walters 212-871-2057 ext 2

subscribe@wallstreetreporter.com.